Back to results
Xarelto Rivaroxaban - prevention of venous thromboembolism after surgery
- Source agency:
- DMTP
- Date of Submission:
- 06/04/2010
- Date of Printing:
- 05/02/2012
- Technology name:
- Xarelto Rivaroxaban - prevention of venous thromboembolism after surgery
- Technology - type(s):
- Drug
- Patient indications:
- For prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery – 10 mg daily from day 1 (6 hours post-operation) continuing for 5 weeks for hip or femoral surgery and 2 weeks for knee surgery post-operation).
Xarelto Rivaroxaban - prevention of venous thromboembolism after surgery